摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4S,5R,13S,14S,15S)-14-Hydroxy-5-isobutyl-15-isopropyl-13-methyl-2,12-dioxo-4-triisopropylsilanyloxy-1-oxa-6,11-diaza-cyclopentadecane-6-carboxylic acid tert-butyl ester | 192211-81-7

中文名称
——
中文别名
——
英文名称
(4S,5R,13S,14S,15S)-14-Hydroxy-5-isobutyl-15-isopropyl-13-methyl-2,12-dioxo-4-triisopropylsilanyloxy-1-oxa-6,11-diaza-cyclopentadecane-6-carboxylic acid tert-butyl ester
英文别名
tert-butyl (4S,5R,13S,14S,15S)-14-hydroxy-13-methyl-5-(2-methylpropyl)-2,12-dioxo-15-propan-2-yl-4-tri(propan-2-yl)silyloxy-1-oxa-6,11-diazacyclopentadecane-6-carboxylate
(4S,5R,13S,14S,15S)-14-Hydroxy-5-isobutyl-15-isopropyl-13-methyl-2,12-dioxo-4-triisopropylsilanyloxy-1-oxa-6,11-diaza-cyclopentadecane-6-carboxylic acid tert-butyl ester化学式
CAS
192211-81-7
化学式
C34H66N2O7Si
mdl
——
分子量
642.993
InChiKey
CCWQLBDTZXFSCC-PABOLRIOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.06
  • 重原子数:
    44
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    114
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (4S,5R,13S,14S,15S)-14-Hydroxy-5-isobutyl-15-isopropyl-13-methyl-2,12-dioxo-4-triisopropylsilanyloxy-1-oxa-6,11-diaza-cyclopentadecane-6-carboxylic acid tert-butyl esterN-甲基吗啉盐酸 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 戴斯-马丁氧化剂 作用下, 以 二氯甲烷乙酸乙酯 为溶剂, 反应 13.5h, 生成 (S)-2-(Acetyl-methyl-amino)-3-(4-methoxy-phenyl)-propionic acid (1R,2S)-2-tert-butoxycarbonylamino-3-((4S,5R,13S,15S)-4-hydroxy-5-isobutyl-15-isopropyl-13-methyl-2,12,14-trioxo-1-oxa-6,11-diaza-cyclopentadec-6-yl)-1-methyl-3-oxo-propyl ester
    参考文献:
    名称:
    Synthesis of a Reduced Ring Analog of Didemnin B
    摘要:
    As part of investigations directed toward the determination of the essential/nonessential structural features for the bioactivities of didemnin B, we designed a reduced ring analog in which three moieties, namely the tyrosine side chain, the isostatine hydroxyl, and the side chain (L-lactyl-L-prolyl-N-Me-D-leucine), were in their presumed bioactive conformation. In designing the reduced ring analog, we eliminated the leucine-proline portion of the macrocycle core and replaced if with an n-butyl linker in order to elucidate its role. According to MM2 calculations (MacroModel molecular modeling), this analog was of lower energy than the natural product didemnin B, and both structures were superimposable. The synthetic strategy involved four disconnections. Macrocyclization was accomplished at the activated carboxylic acid of the alpha-(alpha-hydroxyisovaleryl)-propionyl unit (HIP) and the protected amine of the n-butyl linker using a modification of Schmidt's protocol. After selective deprotection of the hydroxyl and amino groups of the macrocycle, the peptide side chain was introduced using (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) as the activating reagent.
    DOI:
    10.1021/jo9623696
  • 作为产物:
    参考文献:
    名称:
    Synthesis of a Reduced Ring Analog of Didemnin B
    摘要:
    As part of investigations directed toward the determination of the essential/nonessential structural features for the bioactivities of didemnin B, we designed a reduced ring analog in which three moieties, namely the tyrosine side chain, the isostatine hydroxyl, and the side chain (L-lactyl-L-prolyl-N-Me-D-leucine), were in their presumed bioactive conformation. In designing the reduced ring analog, we eliminated the leucine-proline portion of the macrocycle core and replaced if with an n-butyl linker in order to elucidate its role. According to MM2 calculations (MacroModel molecular modeling), this analog was of lower energy than the natural product didemnin B, and both structures were superimposable. The synthetic strategy involved four disconnections. Macrocyclization was accomplished at the activated carboxylic acid of the alpha-(alpha-hydroxyisovaleryl)-propionyl unit (HIP) and the protected amine of the n-butyl linker using a modification of Schmidt's protocol. After selective deprotection of the hydroxyl and amino groups of the macrocycle, the peptide side chain was introduced using (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) as the activating reagent.
    DOI:
    10.1021/jo9623696
点击查看最新优质反应信息

文献信息

  • Synthesis of a Reduced Ring Analog of Didemnin B
    作者:Joshi M. Ramanjulu、Xiaobin Ding、Madeleine M. Joullié、Wen-Ren Li
    DOI:10.1021/jo9623696
    日期:1997.7.1
    As part of investigations directed toward the determination of the essential/nonessential structural features for the bioactivities of didemnin B, we designed a reduced ring analog in which three moieties, namely the tyrosine side chain, the isostatine hydroxyl, and the side chain (L-lactyl-L-prolyl-N-Me-D-leucine), were in their presumed bioactive conformation. In designing the reduced ring analog, we eliminated the leucine-proline portion of the macrocycle core and replaced if with an n-butyl linker in order to elucidate its role. According to MM2 calculations (MacroModel molecular modeling), this analog was of lower energy than the natural product didemnin B, and both structures were superimposable. The synthetic strategy involved four disconnections. Macrocyclization was accomplished at the activated carboxylic acid of the alpha-(alpha-hydroxyisovaleryl)-propionyl unit (HIP) and the protected amine of the n-butyl linker using a modification of Schmidt's protocol. After selective deprotection of the hydroxyl and amino groups of the macrocycle, the peptide side chain was introduced using (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) as the activating reagent.
查看更多